Onderstaande wetenschappelijke literatuur en onderzoeken zijn basis voor de informatie op deze website.

  1. arclay TS, Tsourounus C, Mc Cart GM, Glucosamine. Ann Pharmacother 1998; 32:574-9

  2. Belch JJF (1989) Eicosanoids and rheumatology: inflammatory and vascular aspects. Prostagl Leukotr Ess Fatty Acids 36: 219-234

  3. Berger M, O'Shea J. Cross AS Folks TM Chrused TM Brown EJ, Frank MM (1984) Human neutrophils increase expression of C3bi as well as C3b recptors upon activation. J. Clin Invest 74: 1566-1571

  4. Bijlasma JWJ, Romijnders ACM. Artrose In: Bijlsma JWJ, Voorn ThB. Praktische huisartsgeneeskunde, reumatologie Houten: Bohn Stafleu van Loghum 2000.p.194-205

  5. Bourgeois P, Charles G, Dehais J. Delcambre B, Kuntz JL, Rozenberg S. Efficacy and tolerability of chondroitin sulphate 1200 mg/day vs chondroitin sulphate 3 x 400 mg day vs placebo. Osteoarthritis Cartilage 1998;6Suppl A25:25-30

  6. Brandt KD. Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis? Rheum Dis Clin North Am 1993; 19:24-44

  7. Conrozier T. Les traitements anti-arthrosiques: efficacité et tolerance des chondroitines sulfates (CS 4&6). Presse Med 1998:27:1862-5

  8. Deal CL, Moskowitz RW, Nutraceuticals as therapeutic agents in osteoarthritis: the role of glucosamine, chondroitin sulphate and collagen hydrolysate. Rheum Dis Clin North Am 1999;25:379-95
  9. Gouze JN, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J, et al. Interleukin-1r down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosythesis. Influence of glucosamine on interleukin-Ir-mediated, effects in rat chondrocytes Arthritis Rheum 2001; 44: 351-360.
  10. Griffin MR, Brandt KD, Liang MH, Pincus T, Ray WA, Practical management of osteoarthritis integration of pharmacologic and  nonpharmacologic measures. Arch Fam Med 1995; 4:1049-55

  11. Houpt JB, McMillan R, Wein C, Paget-Dellio SD Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999;26:2423-30

  12. Largo R, Alvarez-Soria MA, Diez-OrtegoI, Calvo E, Sanchez-Pernante O, Egido J et al, Glucosamine inhibits IL-i beta-induced Nfkappa B activation in human osteoarthritic chondrocytes, Osteoarthritis Cartilage, 11: 290-298

  13. Mc Alindon TE, La Valley MP, Gullin JP Felson DT Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75

  14. McKenzie, L.S., Horsburgh, B.A., Ghosh, P. en Taylor, T.K.F., Osteoarthrosis:  Uncertain Rationale for Anti-inflammatory Drug Therapy, Lancet 1: 908-909, 1976.

  15. Palmoski, J.J. en Brandt, K.D., Effects of Some Non-Steroidal Anti inflammatory Drugs Proteoglycan Metabolism and Organization in Canine Articular Cartilage. Arthritis and Reumatism 23:1010-1020, 1980

  16. Pavelka K, Bucsi L, Manopulo R. Double blind, dose effect study of oral Chondroitin 4 &^6 1200 mg against placebo in the treatment of femoro tibial osteoarthritis. Eular Rheumatol Litera 1998;27 Suppl 2:63

  17. Pujalte JM Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin 1980;7:110-4

  18. Reginster JY, Deroisy R, Rovati LC, et al. Long term effects of glucosamine sulphate on osteoarthritis progression: a randomized placebo controlled clinical trial. Lancet 2001; 357:251-6

  19. Reichelt A, Forster KK, Fischer M, Rovati LCLC, Setnikar I Efficancy and safety of intramuscular glucosamine sulphate in osteoarthritis of the knee. A randomised, placebo-controlled, double blind study Arzneimittelforschung 1994:44-75-80.

  20. Vajaradul Y. Double blind clinical evaluation of intra articular glucosamine in outpatients with gonarthrosis. Clin Ther 1981:3:336-43

  21. Vidal y Plana, R.R. Bizzardi, D. En Rovati, A.L., Articular Cartilage Pharmacology : In Vitro Studies on Glucosamine and Non-steroidal Anti inflammatory Drugs. Pharmacological Research Communications 10(6):557-569, 1978.

  22. Vidal y Plana, R.R. Bizzardi, D. En Rovati, A.L., Articular Cartilage Pharmacology : In Vitro Studies on Glucosamine and Non-steroidal Anti inflammatory Drugs. Pharmacological Research Communications 10(6):557-569, 1978.

  23. Towheed TE, Anastassiades TP, Glucosamine therapy for osteoarthritis, J. Rheumatol 1999; 26: 2294-2297.

  24. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY, Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta analysis. Arch Intern Med 2003; 163: 1514-1522.

  25. Cibere J, Kopec JA, Thorne A, Singer J, Canvin J, Robinson DB, et al. Randomized, double-blind, placebo controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 2004; 51: 738-745.

  26. Mc Alindon T, Formica M, La Valley M, Lehmer M, Kabbara. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am I Med 2004; 117:643-649.

  27. Morreale P, Manopulo R, Galati M, Boccanera L, Saponatie J, Bocchi L, Comparison of the anti-inflammatory efficacy of chondroitin sulphate and diclofenac sodium in patients with knee osteoarthritis. J. Rheumatol 1996;23: 1385-1391.

  28. Michel B, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, et al. Chondroitins 4 en 6 sulfate in osteoarthritis of the knee. Arthritis Rheum 2005; 52:  779-786.